Skip to main content
Clinical Trials/NCT02370719
NCT02370719
Terminated
Not Applicable

Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 Diabetes Mellitus

University Health Network, Toronto1 site in 1 country23 target enrollmentJune 28, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes Mellitus
Sponsor
University Health Network, Toronto
Enrollment
23
Locations
1
Primary Endpoint
Change in HbA1c from baseline to 12 months
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to evaluate a patient-centered diabetes self-management mobile application (app), which was developed with feedback from both patients and healthcare providers. During the 12 month randomized control trial, participants in the intervention group will be provided with a mobile phone and commercial home medical devices, such as a weight scale, glucometer and activity monitor. The measurements taken from the medical devices will wirelessly transfer to the mobile phone, where the app will assess the data and provide patients with actionable self-management knowledge. The proposed intervention may be helpful in increasing adherence to recommended self-care practices, improving self-efficacy, and enhancing the overall patient experience.

Registry
clinicaltrials.gov
Start Date
June 28, 2015
End Date
October 28, 2017
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joseph Cafazzo

Senior Director

University Health Network, Toronto

Eligibility Criteria

Inclusion Criteria

  • English-speaking individuals
  • Diagnosed with non-insulin requiring type 2 diabetes
  • Outpatients
  • Baseline A1c of 7.5% or higher

Exclusion Criteria

  • Patients who are deemed unable to use a mobile phone (e.g. due to vision problems), and/or to comply with home monitoring (e.g. suffering from anxiety or depression)
  • Diabetes duration \<1 year

Outcomes

Primary Outcomes

Change in HbA1c from baseline to 12 months

Time Frame: Baseline, 3, 6, 9 and 12 months

Secondary Outcomes

  • Diabetes Distress Scale(Baseline, 6 and 12 months)
  • Blood pressure(Baseline, 3, 6, 9 and 12 months)
  • Cholesterol (LDL and total)(Baseline, 6 and 12 months)
  • Summary of Diabetes Self-Care Activities(Baseline, 6 and 12 months)
  • Medication changes(3, 6, 9 and 12 months)
  • Weight(Baseline, 3, 6, 9 and 12 months)
  • Glycemic excursions(3, 6, 9 and 12 months)
  • BMI(Baseline, 3, 6, 9 and 12 months)
  • Diabetes Empowerment Scale(Baseline, 6 and 12 months)

Study Sites (1)

Loading locations...

Similar Trials